InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,599.60
(
1.04%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.44
(
-0.05%
)
Bitcoin
63,112.88
(
-0.08%
)
Post# of 4273
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

iandy

Send PM Follow Ignore
Followers 18
Posts 3165
Boards Moderated 0
Alias Born 06/09/2010

iandy

Re: MBaker post# 2511

Thursday, 04/27/2017 4:44:20 AM

Thursday, April 27, 2017 4:44:20 AM

Post# of 4273
Too early in the launch to critque.
I sure hope they plan on some direct to consumer advertising and don't rely solely on the reps.
There are a lot of prospective patients that don't frequent a GI specialist on a regular basis, if at all. Some advertising would probably help the stock as well.

If the drug sales go well,the short position should finally dissipate. A hostile takeover might be in order if sales lag Linzess badly. Shame we don't know if there has been interest in partnership or buyout.

Andy
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up